[Application of octrestatin in the treatment of patients with acute pancreatitis].
The influence of preparation Octrestatin, manufactured by Russian company "Pharm-Synthesis", on activity of amylase in the blood and urine in dynamic among 38 operated persons and 79 patients with an acute pancreatitis, who were not operated, was analyzed. There was established high efficacy of Octrestatin application as an inhibitor of pancreatic secretion, possible faster normalization of the amylase activity in the blood and urine, and prophylaxis of the wave-like course of the disease also.
Riazanov
D Iu
DIu
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000681:Amylases / Q000097:blood / Q000652:urine; D004334:Drug Administration Schedule; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage / Q000627:therapeutic use*; D010195:Pancreatitis / Q000188:drug therapy* / Q000201:enzymology / Q000601:surgery; D016896:Treatment Outcome
D005765:Gastrointestinal Agents; D000681:Amylases; D015282:Octreotide